Grape King Bio Ltd Cash Flow Conversion Efficiency
Grape King Bio Ltd cash flow conversion efficiency. Based on the latest financial reports, Grape King Bio Ltd (1707) has a cash flow conversion efficiency ratio of 0.024x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$278.74 Million ≈ $8.78 Million USD) by net assets (NT$11.60 Billion ≈ $365.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Grape King Bio Ltd stock valuation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Grape King Bio Ltd (2002–2025)
Cash flow conversion efficiency of Grape King Bio Ltd from 2002 to 2025. This chart illustrates how Grape King Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Grape King Bio Ltd share price for real-time trading data and today's change.
Grape King Bio Ltd Cash Flow Conversion Ratio Explained
Grape King Bio Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Grape King Bio Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Grape King Bio Ltd ranked by their cash flow conversion efficiency. Review how much free cash does Grape King Bio Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
First Carolina Financial Services, Inc.
NYSE:FCBM
|
0.014x |
|
Miwon Commerci
KO:002840
|
0.024x |
|
Invesco Mortgage Capital Inc
NYSE:IVR
|
0.047x |
|
Huang Hsiang Construction Corp
TW:2545
|
-0.054x |
|
Hangzhou Huaxing Chuangye Communication Technology Co Ltd
SHE:300025
|
-0.007x |
|
OceanPact Serviços Marítimos S.A
SA:OPCT3
|
0.143x |
|
Beijing Integrity Technology Co. Ltd. A
SHG:688244
|
N/A |
|
Fujian Oriental Silver Star Investment Co Ltd
SHG:600753
|
-0.095x |
Annual Cash Flow Conversion Efficiency for Grape King Bio Ltd (2002–2025)
The table below shows the annual cash flow conversion efficiency of Grape King Bio Ltd from 2002 to 2025. Also see 1707 current and non-current assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$12.07 Billion ≈ $380.16 Million |
NT$2.18 Billion ≈ $68.68 Million |
0.181x | +13.55% |
| 2024-12-31 | NT$11.79 Billion ≈ $371.47 Million |
NT$1.88 Billion ≈ $59.10 Million |
0.159x | -26.56% |
| 2023-12-31 | NT$11.63 Billion ≈ $366.41 Million |
NT$2.52 Billion ≈ $79.37 Million |
0.217x | -19.29% |
| 2022-12-31 | NT$11.14 Billion ≈ $351.00 Million |
NT$2.99 Billion ≈ $94.22 Million |
0.268x | +10.12% |
| 2021-12-31 | NT$10.43 Billion ≈ $328.58 Million |
NT$2.54 Billion ≈ $80.09 Million |
0.244x | -28.48% |
| 2020-12-31 | NT$7.98 Billion ≈ $251.37 Million |
NT$2.72 Billion ≈ $85.67 Million |
0.341x | +17.26% |
| 2019-12-31 | NT$7.47 Billion ≈ $235.37 Million |
NT$2.17 Billion ≈ $68.41 Million |
0.291x | -16.64% |
| 2018-12-31 | NT$6.93 Billion ≈ $218.44 Million |
NT$2.42 Billion ≈ $76.16 Million |
0.349x | -11.59% |
| 2017-12-31 | NT$6.33 Billion ≈ $199.37 Million |
NT$2.50 Billion ≈ $78.63 Million |
0.394x | -18.64% |
| 2016-12-31 | NT$5.78 Billion ≈ $182.19 Million |
NT$2.80 Billion ≈ $88.31 Million |
0.485x | +56.50% |
| 2015-12-31 | NT$4.22 Billion ≈ $132.94 Million |
NT$1.31 Billion ≈ $41.18 Million |
0.310x | -32.34% |
| 2014-12-31 | NT$3.72 Billion ≈ $117.10 Million |
NT$1.70 Billion ≈ $53.60 Million |
0.458x | -6.43% |
| 2013-12-31 | NT$3.22 Billion ≈ $101.47 Million |
NT$1.58 Billion ≈ $49.65 Million |
0.489x | +19.64% |
| 2012-12-31 | NT$2.74 Billion ≈ $86.39 Million |
NT$1.12 Billion ≈ $35.33 Million |
0.409x | +19.10% |
| 2011-12-31 | NT$2.47 Billion ≈ $77.86 Million |
NT$848.53 Million ≈ $26.73 Million |
0.343x | +13.46% |
| 2010-12-31 | NT$2.26 Billion ≈ $71.20 Million |
NT$683.89 Million ≈ $21.55 Million |
0.303x | -12.82% |
| 2009-12-31 | NT$2.08 Billion ≈ $65.40 Million |
NT$720.61 Million ≈ $22.70 Million |
0.347x | +39.24% |
| 2008-12-31 | NT$1.74 Billion ≈ $54.95 Million |
NT$434.85 Million ≈ $13.70 Million |
0.249x | +74.65% |
| 2007-12-31 | NT$1.77 Billion ≈ $55.86 Million |
NT$253.11 Million ≈ $7.97 Million |
0.143x | -48.28% |
| 2006-12-31 | NT$1.70 Billion ≈ $53.52 Million |
NT$468.84 Million ≈ $14.77 Million |
0.276x | +26.09% |
| 2005-12-31 | NT$1.60 Billion ≈ $50.42 Million |
NT$350.26 Million ≈ $11.04 Million |
0.219x | +597.83% |
| 2004-12-31 | NT$1.58 Billion ≈ $49.75 Million |
NT$49.53 Million ≈ $1.56 Million |
0.031x | -65.88% |
| 2003-12-31 | NT$1.48 Billion ≈ $46.75 Million |
NT$136.42 Million ≈ $4.30 Million |
0.092x | +75.77% |
| 2002-12-31 | NT$1.46 Billion ≈ $46.03 Million |
NT$76.42 Million ≈ $2.41 Million |
0.052x | -- |
About Grape King Bio Ltd
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; a… Read more